Charles R. Romp
Net Worth

Last updated:

What is Charles R. Romp net worth?

The estimated net worth of Mr. Charles R. Romp is at least $5,984,950 as of 21 Sep 2023. He has earned $1,839,150 from insider trading and has received compensation worth at least $4,145,800 in Seagen Inc..

What is the salary of Charles R. Romp?

Mr. Charles R. Romp salary is $829,160 per year as Executive Vice President of Commercial U.S. in Seagen Inc..

How old is Charles R. Romp?

Mr. Charles R. Romp is 57 years old, born in 1968.

What stocks does Charles R. Romp currently own?

As insider, Mr. Charles R. Romp owns shares in one company:

Company Title Shares Price per share Total value
Seagen Inc. (SGEN) Executive Vice President of Commercial U.S. 69,111 $0 $0

What does Seagen Inc. do?

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.

SGEN logo
SGEN
Seagen Inc.

Charles R. Romp insider trading

Seagen Inc.

Mr. Charles R. Romp has made 30 insider trades between 2020-2023, according to the Form 4 filled with the SEC. Most recently he sold 45 units of SGEN stock worth $9,293 on 21 Sep 2023.

The largest trade he's ever made was exercising 14,079 units of SGEN stock on 4 Nov 2020. As of 21 Sep 2023 he still owns at least 69,111 units of SGEN stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 45 $206.5 $9,293
Sale
Common Stock 555 $206.97 $114,866
Sale
Common Stock 438 $206 $90,228
Sale
Common Stock 708 $192.46 $136,262
Sale
Common Stock 349 $189.86 $66,261
Sale
Common Stock 133 $205.86 $27,379
Sale
Common Stock 1,129 $127.63 $144,094
Sale
Common Stock 578 $154.42 $89,252
Sale
Common Stock 555 $154.42 $85,700
Sale
Common Stock 988 $170.22 $168,172
Sale
Common Stock 777 $170.22 $132,257
Sale
Common Stock 712 $179.46 $127,776
Sale
Common Stock 333 $134.21 $44,691
Sale
Common Stock 319 $144.32 $46,038
Sale
Common Stock 1,323 $149.85 $198,252
Sale
Common Stock 1,133 $167.52 $189,796
Sale
Common Stock 777 $154.55 $120,088
Sale
Common Stock 703 N/A N/A
Sale
Common Stock 334 $145.95 $48,746
Option
Common Stock 7,666 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 7,666 N/A N/A
Sale
Common Stock 7,666 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 6,000 N/A N/A
Sale
Common Stock 6,000 N/A N/A
Option
Common Stock 6,000 N/A N/A
Sale
Common Stock 1,590 N/A N/A
Option
Incentive Stock Option (right to buy) 417 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 1,590 N/A N/A
Option
Common Stock 14,079 N/A N/A
Option
Common Stock 5,197 N/A N/A
Option
Incentive Stock Option (right to buy) 2,778 N/A N/A
Sale
Common Stock 2,484 N/A N/A
Sale
Common Stock 13,001 N/A N/A
Sale
Common Stock 1,133 N/A N/A
Sale
Common Stock 4,027 N/A N/A
Sale
Common Stock 712 N/A N/A
Sale
Common Stock 6,942 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 6,942 N/A N/A
Option
Common Stock 6,942 N/A N/A
Option
Common Stock 6,942 N/A N/A
Sale
Common Stock 6,942 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 6,942 N/A N/A
Sale
Common Stock 5,056 N/A N/A

Seagen key executives

Seagen Inc. executives and other stock owners filed with the SEC: